PEFAKIT

DSM IP Assets B.V.

Application Filed: 2010-09-17

Trademark Application Details

Status

739

Live/Registered

Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED

Research	OneLook Acronym Finder
Serial Number	79091943
Registration Number	4107292
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	DUANE M. BYERS
Attorney Docket Number	4662-2298
Law Office Assigned	L40
Employee Name	FINNEGAN, TIMOTHY J

Timeline

2010-09-17	Application Filed
2011-12-20	Published for Opposition
2012-03-06	Trademark Registered
2018-03-12	Location: GENERIC WEB UPDATE
2018-03-12	Status: Live/Registered
2019-05-30	Transaction Date

Trademark Applicants & Owners

Owner:	DSM IP Assets B.V.
Entity Statement	Besloten Vennootschap
Address	Het Overloon 1 NL-6411 TE Heerlen NL
Legal Entity Type
Legal Entity State	NL

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

DUANE M. BYERS
NIXON & VANDERHYE P.C.
11TH FLOOR
901 NORTH GLEBE ROAD
ARLINGTON, VA 22203-1808

Good, Services, and Codes

International Codes:	1
U.S. Codes:	001,005,006,010,026,046
International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0011	Chemical preparations for pharmaceutical or medical purposes, namely, for the detection of fibrinogen polymerization disorders, determination of initial thrombin formation by intrinsic activation, determination of factor Xa and factor lla inhibitors and determination of resistance of Factor Va to inactivation by activated protein C, namely, APC, caused by the factor V Leiden mutation, namely, FV: Q506; diagnostic preparations for medical purposes

Type Code

Type

GS0011

Chemical preparations for pharmaceutical or medical purposes, namely, for the detection of fibrinogen polymerization disorders, determination of initial thrombin formation by intrinsic activation, determination of factor Xa and factor lla inhibitors and determination of resistance of Factor Va to inactivation by activated protein C, namely, APC, caused by the factor V Leiden mutation, namely, FV: Q506; diagnostic preparations for medical purposes

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB	2011-01-27	1 SDRC M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-02-01	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-02-01	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2011-02-02	4 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2011-02-03	5 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2011-02-03	6 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2011-02-03	7 RFCS P:
APPLICATION FILING RECEIPT MAILED	2011-02-05	8 MAFR O:Outgoing Correspondence
REFUSAL PROCESSED BY IB	2011-02-19	9 RFNT P:
TEAS PETITION TO REVIVE RECEIVED	2011-08-08	10 PROA I:Incoming Correspondence
PETITION TO REVIVE-GRANTED	2011-08-08	11 PETG O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2011-08-08	12 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2011-08-08	13 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2011-08-08	14 TEME I:Incoming Correspondence
FINAL REFUSAL WRITTEN	2011-09-04	15 CNFR R:Renewal
FINAL REFUSAL MAILED	2011-09-06	16 CNFR O:Outgoing Correspondence
EXAMINERS AMENDMENT -WRITTEN	2011-11-04	17 CNEA R:Renewal
ASSIGNED TO LIE	2011-11-04	18 ALIE A:Allowance for Publication
EXAMINER'S AMENDMENT ENTERED	2011-11-05	19 XAEC I:Incoming Correspondence
EXAMINERS AMENDMENT MAILED	2011-11-07	20 CNEA O:Outgoing Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-11-12	21 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED	2011-11-16	22 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2011-11-30	23 NPUB O:Outgoing Correspondence
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	2011-11-30	24 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	2011-11-30	25 OPNS P:
PUBLISHED FOR OPPOSITION	2011-12-20	26 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2012-03-06	27 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2012-06-06	28 FICR P:
FINAL DISPOSITION PROCESSED	2012-09-24	29 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2012-09-24	30 FICS P:
NOTIFICATION PROCESSED BY IB	2012-10-13	31 GPNX P:
PAPER RECEIVED	2012-12-17	32 MAIL I:Incoming Correspondence
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED	2013-01-08	33 CORV 1:
FINAL DECISION TRANSACTION PROCESSED BY IB	2013-03-19	34 FINO P:
TEAS SECTION 71 & 15 RECEIVED	2018-02-21	35 ES75 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2018-03-12	36 APRE A:Allowance for Publication
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.	2018-03-12	37 C75A O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	2018-03-12	38 NA75 E:E-Mail
INTERNATIONAL REGISTRATION RENEWED	2019-05-30	39 RNWL P:
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	2021-03-06	40 REM4 E:E-Mail
TEAS SECTION 71 RECEIVED	2022-02-25	41 ES71 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2022-08-02	42 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED	2022-08-08	43 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2022-08-08	44 NA71 E:E-Mail
CHANGE OF OWNER RECEIVED FROM IB	2023-01-07	45 CHLD M:

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
PEFAKIT 79091943 4107292 Live/Registered	DSM IP Assets B.V. 2010-09-17
PEFAKIT 75682152 2395142 Live/Registered	DSM IP ASSETS B.V. 1999-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.